Alphapharm Concedes To Forest Labs In Antidepressant Battle
Alphapharm, part of the generics division of Germany-based Merck KGaA, was sued by New York-based Forest and its Danish licensing partner H. Lundbeck A/S in U.S. District Court for the Southern District of New York. The case was transferred four months later to Delaware.
The settlement relieves Forest of a challenge that threatened its most lucrative...
To view the full article, register now.